Maheshika Kuruppuarachchi
Polyacrylamide nanoparticles as a delivery system in photodynamic therapy
Kuruppuarachchi, Maheshika; Lowry, Ann; Savoie, Huguette; Alonso, Cristina; Boyle, Ross W.
Authors
Ann Lowry
Huguette Savoie
Cristina Alonso
Professor Ross Boyle R.W.Boyle@hull.ac.uk
Professor of Biological Chemistry
Abstract
Nanoparticles can be targeted towards, and accumulate in, tumor tissue by the enhanced permeability and retention effect, if sequestration by the reticuloendothelial system (RES) is avoided. The application of nanoparticles in the field of drug delivery is thus an area of great interest, due to their potential for delivering high payloads of drugs site selectively. One area which may prove to be particularly attractive is photodynamic therapy, as the reactive oxygen species (ROS) which cause damage to the tumor tissue are not generated until the drug is activated with light, minimizing generalized toxicity and giving a high degree of spatial control over the clinical effect. In the present study, we have synthesized two types of nanoparticles loaded with photodynamic sensitizers: polylysine bound tetrasulfonato-aluminum phthalocyanine entrapped nanoparticles (PCNP) and polylysine bound tetrasulfonato-aluminum phthalocyanine entrapped nanoparticles coated with a second, porphyrin based, photosensitizer (PCNP-P) to enhance the capacity for ROS generation, and hence therapeutic potential. The mean sizes of these particles were 45 +/- 10 nm and 95 +/- 10 nm respectively. Uptake of the nanoparticles by human Caucasian colon adenocarcinoma cells (HT29) was determined by flow cytometry and confocal microscopy. Cell viability assays using PCNP-P and PCNP corresponding to the minimum uptake time (25 h) demonstrated that these cancer cells can be damaged by light activation of these photodynamic nanoparticles both in the external media and after internalization. The results suggest that, in order to induce photodynamic damage, the nanoparticles need only to be associated with the tumor cell closely enough to deliver singlet oxygen: their internalization within target cells may not be necessary. Clinically, this could be of great importance as it may help to combat the known ability of many cancer cells to actively expel conventional anticancer drugs.
Citation
Kuruppuarachchi, M., Lowry, A., Savoie, H., Alonso, C., & Boyle, R. W. (2011). Polyacrylamide nanoparticles as a delivery system in photodynamic therapy. Molecular pharmaceutics, 8(3), 920-931. https://doi.org/10.1021/mp200023y
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 16, 2011 |
Online Publication Date | Mar 16, 2011 |
Publication Date | Jun 6, 2011 |
Deposit Date | Nov 13, 2014 |
Publicly Available Date | Nov 13, 2014 |
Journal | Molecular Pharmaceutics |
Print ISSN | 1543-8384 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 8 |
Issue | 3 |
Pages | 920-931 |
DOI | https://doi.org/10.1021/mp200023y |
Keywords | PDT; porphyrins; phthalocyanine; nanoparticles; drug delivery; localized embedding pebbles; drug-delivery; living cells; cancer-therapy; macrophage endocytosis; optical nanosensors; oxygen photosensitizers; mechanisms; porphyrin, |
Public URL | https://hull-repository.worktribe.com/output/463242 |
Contract Date | Nov 13, 2014 |
Files
Mol Pharm. Nano PDT 2011.pdf
(4.8 Mb)
PDF
You might also like
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search